----

**Exhibit      10.113**

**2007      VeriChip Corporation Executive Management Incentive Plan **

|   |         |                                                            |
|--------|--------------|-----------------------------------------------------------------|
| To:    |    | Executive                Management                             |
| From:  |    | Compensation                Committee of the Board of Directors |
| Date:  |    | April                2, 2007                                    |

**Re:      2007 VeriChip Corporation Executive Management Incentive Plan**

|   | 1. | Consolidated                revenue for 2007 |
|--------|----|----------------------------------------------|

|   | 2. | Implantable                division revenue for 2007 |
|--------|----|------------------------------------------------------|

|   | 3. | 2007                year end common stock price per share |
|--------|----|-----------------------------------------------------------|

|   | 4. | Cash                balance as of December 31, 2007 |
|--------|----|----------------------------------------------------------|

|   | 5. | Strategic                partnerships and distribution agreements |
|--------|----|-------------------------------------------------------------------|

|   | 6. | Strategic                acquisition |
|--------|----|--------------------------------------|

|   | 7. | EBITDA                of Canadian operations |
|--------|----|----------------------------------------------|

|   | 8. | Infrastructure                build out targets for VeriMed business |
|--------|----|----------------------------------------------------------------------|

|   | 9. | Analyst                coverage for common stock |
|--------|----|--------------------------------------------------|

|   | 10. | SOX                and financial audit |
|--------|-----|----------------------------------------|

|   | 11. | Discretionary                by Compensation Committee of the Board |
|--------|-----|---------------------------------------------------------------------|

----

**Summary      of Calculation of Bonus **

|                                                                                                                                                        | **Silverman**                | **Caragol**                 | **Feder**                   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|-----------------------------|-----------------------------|
| Consolidated                revenue of $32.0 million for 2007                                                                                               | 3                            | 2                           | 0.5                         |
| Consolidated                revenue of $33.6 million for 2007                                                                                               | 1                            | 1                           | 1                           |
| Consolidated                revenue of $35.2 million for 2007                                                                                               | 1                            | 1                           | 1                           |
| Implantable                revenue of $250 thousand for 2007                                                                                                | 1                            | 0.5                         | 0.5                         |
| Implantable                revenue of $500 thousand for 2007                                                                                                | 1                            | 0.5                         | 0.5                         |
| Implantable                revenue of $750 thousand for 2007                                                                                                | 1                            | 0.5                         | 0.5                         |
| Implantable                revenue of $1.0 million for 2007                                                                                                 | 1                            | 0.5                         | 0.5                         |
| Implantable                revenue of $2.5 million for 2007                                                                                                 |                         |                        | 1                           |
| December 31,                2007 common stock price in excess of IPO price                                                                             | 2                            | 0.67                        |                        |
| December 31,                2007 common stock price 25% in excess of IPO price                                                                         | 1                            | 0.33                        |                        |
| Total                cash at December 31, 2007 of $8.5 million                                                                                         | 1                            | 1                           |                        |
| Strategic                partnership and distribution agreements (other than Henry                Schein)                                                   | 1                            | 0.5                         | 1                           |
| Strategic                acquisition                                                                                                                        | 1                            | 0.5                         |                        |
| EBITDA                of Canadian operations of $4.8 million                                                                                                | 2                            | 1                           |                        |
| SOX                404 and audit opinion without material deficiencies                                                                                      | 1                            | 1                           |                        |
| VeriMed                hospitals in network of 800 at December 31, 2007 and protocol adopted                hospitals of 200 at December 31, 2007 | 1                            | 0.5                         | 2                           |
| Analyst                coverage by three equity research analysts                                                                                           | 2                            | 1                           |                        |
| Discretionary                by the Compensation Committee                                                                                                  | Up to 10 pts. | Up to 5 pts. | Up to 2 pts. |
| TOTAL                POINT POTENTIAL                                                                                                                        | 31                pts.       | 17.5                pts.    | 10.5                pts.    |

**Notes:      **

|   | 1. | No                executive can earn more than 100% of points listed for that item. |
|--------|----|-------------------------------------------------------------------------------------|

|   | 2. | Revenue                based points are incremental at each new level. For example, for                Mr. Silverman’s point accumulation - at $34 million of consolidated                revenue 4 points are earned (3 points for $32 million, plus 1 point                for                reaching $33.6 million) |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | EBITDA                is determined after giving effect to Canadian management bonuses,                but                before the impact of any bonus to the CEO of VeriChip Corporation,                a                Canadian corporation. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | The                year end stock price shall be calculated based on the average of                the                ending price on the last twenty trading days of the year. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|